Acceleron Pharma to Present at Piper Jaffray 27th Annual Healthcare Conference
24 Noviembre 2015 - 3:05PM
Business Wire
Acceleron Pharma Inc. (NASDAQ: XLRN), a clinical stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel therapeutic candidates that regulate
cellular growth and repair, today announced it will present a
corporate overview at the Piper Jaffray 27th Annual Healthcare
Conference on Tuesday, December 1, 2015 at 3:00 PM EST at The New
York Palace Hotel in New York City.
A live audio webcast of the presentation will be available on
the “Events and Presentations” page in the Investors & Media
section on the Company’s website (www.acceleronpharma.com). A
replay of the webcast will also be available from Acceleron’s
website.
About Acceleron
Acceleron is a clinical stage biopharmaceutical company focused
on the discovery, development and commercialization of novel
therapeutic candidates that regulate cellular growth and repair.
The company is a leader in understanding the biology of the
Transforming Growth Factor-Beta protein superfamily, a large and
diverse group of molecules that are key regulators in the growth
and repair of tissues throughout the human body, and in targeting
these pathways to develop important new medicines. Acceleron has
built a highly productive R&D platform that has generated
innovative clinical and preclinical therapeutic candidates with
novel mechanisms of action. These therapeutic candidates have the
potential to significantly improve clinical outcomes for patients
with cancer and rare diseases.
For more information, please visit www.acceleronpharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151124006188/en/
Acceleron Pharma Inc.Todd James, 617-649-9393Senior Director,
Corporate CommunicationsorBMC Communications LLCBrad Miles,
646-513-3125
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Acceleron Pharma (NASDAQ:XLRN)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Acceleron Pharma Inc (NASDAQ): 0 recent articles
Más de Acceleron Pharma Inc. (MM) Artículos de Noticias